The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
DL-2-[3'-(3''-tert-Butyl-5'',9''-dimethyl-7''-oxo-7H-furo[3,2-g][1]benzopyran-6''-yl)propionylamino]-3-phenylpropionic acid ID: ALA2322558
PubChem CID: 3377704
Max Phase: Preclinical
Molecular Formula: C29H31NO6
Molecular Weight: 489.57
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(CCC(=O)NC(Cc2ccccc2)C(=O)O)c(=O)oc2c(C)c3occ(C(C)(C)C)c3cc12
Standard InChI: InChI=1S/C29H31NO6/c1-16-19(11-12-24(31)30-23(27(32)33)13-18-9-7-6-8-10-18)28(34)36-26-17(2)25-21(14-20(16)26)22(15-35-25)29(3,4)5/h6-10,14-15,23H,11-13H2,1-5H3,(H,30,31)(H,32,33)
Standard InChI Key: KIEVDFRSMMJDAN-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
13.5577 -30.2305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5559 -28.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2645 -28.9984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2679 -29.8236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9803 -30.2310 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6938 -29.8177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6904 -28.9925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9735 -28.5806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8496 -29.8215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8509 -29.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0703 -28.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5867 -29.4091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0684 -30.0740 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8190 -27.9680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3667 -27.3615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0199 -27.7968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6016 -27.1737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9690 -27.7634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4026 -30.2244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3969 -28.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5562 -31.0477 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1059 -28.9882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8123 -28.5774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8098 -27.7602 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5213 -28.9838 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2277 -28.5730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9367 -28.9794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6431 -28.5686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3488 -28.9748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0547 -28.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0526 -27.7466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3387 -27.3404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6356 -27.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2227 -27.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9291 -27.3434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5137 -27.3478 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9 1 1 0
1 4 2 0
3 2 2 0
2 10 1 0
3 4 1 0
3 8 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 9 1 0
11 14 1 0
14 15 1 0
14 16 1 0
14 17 1 0
8 18 1 0
6 19 2 0
7 20 1 0
1 21 1 0
20 22 1 0
22 23 1 0
23 24 2 0
23 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 28 1 0
34 35 1 0
34 36 2 0
26 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 489.57Molecular Weight (Monoisotopic): 489.2151AlogP: 5.20#Rotatable Bonds: 7Polar Surface Area: 109.75Molecular Species: ACIDHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.57CX Basic pKa: ┄CX LogP: 5.38CX LogD: 2.03Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.35Np Likeness Score: -0.23
References 1. Marzaro G, Guiotto A, Borgatti M, Finotti A, Gambari R, Breveglieri G, Chilin A.. (2013) Psoralen derivatives as inhibitors of NF-κB/DNA interaction: synthesis, molecular modeling, 3D-QSAR, and biological evaluation., 56 (5): [PMID:23414143 ] [10.1021/jm3009647 ]